We are monitoring the impact of COVID-19 on IVD Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 121
Share on
Share on

Global In-Vitro Diagnostics Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report - Segmented By Product, IVD Technology, Application and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 121
Pages: 180

Global IVD Market Size (2021 to 2026)

As per our analysis report, the size of the global In-Vitro Diagnostics market is estimated to value USD 73.93 billion in 2021. This figure is forecasted to grow USD 97.08 billion by 2026, growing at a compound annual growth rate (CAGR) of 5.6%.

A recent survey by physicians in the U.S and Germany reported that 66% of clinical decisions would occur based on diagnostic tests. IVD shows beneficial effects on treatment outcomes, therapy choices, and others. In-vitro diagnostics are performed under a specified condition in a test tube. These procedures will help to monitor the health problems of the people. The main aim of the research centers is to develop innovative methods using in-vitro diagnostics. These before have a prominent role in overcoming health-related issues globally.

The Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) has been established by the World Health Organization (WHO) to look over policies and strategies over IVD. It is to set new evidence-based guidance to the scientists to promote in-vitro diagnostics tests. These policies are highly successful in reducing the prices of medicines.

COVID-19 impact on the global IVD Market:

From January 2020, the scientists have focused on developing various kits as the pandemic COVID-9 outbreak is surging across the globe. The impact of this crisis is sharply affecting the demand of the IVD market. Prior diagnosing analysis to track the people affected by the diseases mainly propels the need for this market nowadays. The spread of COVID-19 has been slowed down in China due to their efforts in diagnostic testing. It has made the pharmaceutical companies address these needs and develop kits to test COVID-19. South Korea also grabbed attention in testing a greater number of people in a short period. IVD is a boom for this country, which played an essential role in the healthcare centers during the pandemic situation.

MARKET DRIVERS:

The soaring aging population is driving the global IVD industry growth.

According to the World Health Organization, the number of people aged above 65 is estimated to reach 1.5 billion by 2050. Diseases such as Cancer, Alzheimer’s, arthritis, and others maintain a robust correlation with aging. In the treatment procedures, the laboratories use immunoassay-based tests at an aggressive level, which is expected to drive the in-vitro diagnostics market. Increasing demand to provide appropriate treatment services is leveling up the need of this market to the extent.

The prevalence of automatic IVD systems in hospitals and laboratories is likely to boost in-vitro diagnostics market growth.

IVD systems are very useful in diagnosing the disease as a patient can ensure proper treatment procedures. The emergence of advanced technologies in healthcare hit laboratories where the demand for automatic systems is growing steadily. It is solely to fuel the growth rate of the market. The rising prevalence of user-friendly devices in laboratories is significantly influencing the demand of the market.

The growing population suffering from chronic and infectious diseases is another major factor boosting the global IVD market.

The adoption of sedentary lifestyle changes is leading to an increase in the number of chronic diseases. Growing incidences of chronic and infectious diseases are majorly fueling the growth rate of the market. Increasing awareness towards OTC (over-the-counter) devices is likely to boost the market IVD industry demand.  

MARKET RESTRAINTS:

The shortage of skilled persons in performing these procedures effectively due to fewer training programs and the fluctuations in the prices of final products used in the laboratories slightly hamper the demand of the global in-vitro diagnostics market. Furthermore, the government's stringent rules and regulations for approving newly launched products and the lack of standardization, other attributes declining the growth are some of the other challenging factors for the global IVD market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, Technology, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Market Leaders Profiled

Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, Beckman Coulter Inc., Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories Danaher Corporation, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

 

This research report on the global in-vitro diagnostics market has been segmented and sub-segmented based on the product, technology, application, and region. 

IVD Market - By Product:

  • Instruments
  • Reagents and Kits
  • Software

Based on the product analysis, the Reagents and Kits segment was the leader among all in 2019 and is estimated to continue the same during the forecast period. Increasing the utilization of different devices in laboratories to ensure performance levels in the biotechnology field is prompting the market's demand. Growing usage of various kinds of tools in hospitals and laboratories are some factors that are propelling the in-vitro diagnostics market growth.

The instruments segment is another segment estimated to witness a healthy CAGR during the forecast period after the reagents and kits segment. Adopting advanced technologies and the entry of new players are some of the factors that boost the market growth.

IVD Market - By Technology:

  • Clinical Chemistry
  • Hematology
  • Immunoassays
  • Coagulation and Hemostasis
  • Molecular Diagnostics
  • Microbiology
  • Other IVD technologies

Based on technology, the Clinical chemistry segment held the most significant shares of the market in 2019. Raising awareness is a vital factor for the segment to grow enormously. Increasing demand to develop quality products with the help of appropriate technology is leveraging the market's need. 

The molecular diagnostics and immunoassays segments are growing at healthy growth rates during the forecast period. Increasing incidences of infectious diseases and different genetic disorders are crucial factors for the segment to grow.

IVD Market - By Application:

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • HIV

Based on application, the Oncology/Cancer segment has the fastest growth rate from recent years and continues the same in the coming years. The growing aging population is one of the most common factors gearing up the demand of the market.  The infectious diseases segment is the second-largest segment that holds the market growth due to the common infectious diseases like multi-drug resistant infections.

IVD Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North American IVD Market was the largest market for In-Vitro diagnostics, accounting for around 37% in 2020, owing to the growing prevalence of chronic diseases such as cancer and respiratory diseases in the region. In comparison, the U.S. IVD market has a positive growth rate. The introduction of new diagnostic procedures that are simple and convenient for the technicians operating the systems is leveling up the market's growth. On the other end, the Canadian IVD market is forecasted to grow at a significant CAGR of 6.1% between 2020 to 2025.

The Asia-Pacific IVD market is the fastest-growing segment, with a CAGR of 6.4%. The Asia Pacific is following North America is dominating the shares of the global in-vitro diagnostics market with the rise in the number of health disorders due to changes in lifestyles and food habits. IVD market in India has prominent shares in the APAC IVD market by changes in the government's schemes. Also, the launch of reimbursement schemes favoring ordinary people is leveraging the demand of the market. The Indian IVD market was growing more aggressively among different Asia-Pacific nations and expected to witness a CAGR of 6.9% during the forecast period.

The European IVD Market is growing tremendously over recent years and is to hit the highest CAGR shortly. Increasing demand for point-of-care testing devices is gearing up the need of the market. In 2019, the UK IVD market was the most dominant regional market in the European IVD market and predicted to grow at a CAGR of 6.5% from 2021 to 2026 and worth USD 2980 million in 2020. The German IVD market is another lucrative regional market in Europe and was considered one of the largest in Europe in 2019. The IVD market in Germany is projected to register a CAGR of 5.1% between 2020 to 2025.

The IVD market in the Latin American region is predicted to showcase a CAGR of 5.9% from 2021 to 2026. In Latin America, the IVD market in Brazil was growing consistently and is forecasted to witness a CAGR of 4.98% during the forecast period. Followed by Brazil, the Mexican IVD market is estimated to register a healthy growth rate during the forecast period.

The Middle East and Africa IVD Market to have a slight inclination in the growth rate in the coming years. UAE led this regional market in the recent past, and the UAE market was worth USD 321 million in 2020 and is estimated to grow at a CAGR of 5.12% during the forecast period.

KEY MARKET LEADERS IN THE IVD MARKET:

Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, and Beckman Coulter Inc. are the major players dominating the global IVD market.

Other companies that account for a significant share in the IVD market are Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

RECENT MARKET DEVELOPMENTS:

Product Launches:

  • On April 11, 2019, to fight against cancer, Sophia genetics took a step forward in announcing the CE-IVD marking of its Solid Tumor Solution (STS). This application can detect different types of solid tumors such as lung, colorectal, skin, and brain cancers.
  • On April 19, 2019, Altona diagnostics GmbH announced the launch of the Altostar Molecular Diagnostic workflow. It is a CE-marked device with several benefits such as flexibility and very efficient in testing infectious diseases.
  • On November 27, 2018, the first automated in vitro diagnostic (IVD) named Roche launched VENTANA pan-TRK (EPR17341) Assay. This launch is beneficial in the laboratories to detect tropomyosin receptor kinase (TRK) proteins in cancer.
  • On July 11, 2018, Namsa announced the Launch of IVD development services through integrated laboratory testing. This company is to put complete efforts into manufacturing capable devices in favor of the end-users.
  • On December 28, 2018, Genesig Real-Time PCR Epstein-Barr Virus (EBV) Kit and Genesig Real-Time PCR BK virus (BKV) Kit were launched by Novacyt. These two kits are under the name of CE-IVD mark molecular diagnostic kits. These kits are very accurate in diagnosing the disease and are quite easy to handle in real-time applications.
  • On July 31, 2018, Surmodics, Inc. introduced Matrix Guard Diluent; this move helped their shares eventually propel. The kit is to reduce false-positive results while performing tests using IVD.

Product Approvals:

  • On July 12, 2019, the Abbott IVD system had clearance from the FDA for screening blood and plasma donations. This system has additional automatic features where it can run up to 3 hours without human effort. It has the capacity of doing 600tests per hour.
  • On March 06, 2019, Instrumentation Laboratory (IL) has received approval from U.S Food and drug administration for the innovative product GEM Premier ChemSTAT in vitro diagnostic (IVD) analyzer. It is developed with intelligent quality management where it is broadly used in the point of care testing, primarily in hospital Emergency Departments and clinical laboratories.

Collaborations/Partnerships:

  • On August 03, 2019, Sysmex, a leading company supporting IVD instruments, has agreed with JVCKENWOOD Corporation to manufacture IVD biodevices. These companies are to make better use of micro and nanofabrication technology in developing useful IVD devices.
  • On November 09, 2019, Lexent Bio signed a partnership with Illumina, Inc. to develop a next-generation sequencing IVD kit to diagnose cancer. This product is to promote companies portfolios to the next level.
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Product
      1. Introduction
      2. Instruments
      3. Reagents and Kits
      4. Software
    2. Technology
      1. Introduction
      2. Clinical Chemistry
      3. Haematology
      4. Immunoassays
      5. Coagulation and Hemostasis
      6. Molecular Diagnostics
      7. Microbiology
      8. Other IVD technologies
    3. Application
      1. Introduction
      2. Diabetes
      3. Infectious Diseases
      4. Oncology/Cancer
      5. Cardiology
      6. Nephrology
      7. Autoimmune Diseases
      8. Drug Testing
      9. HIV
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
    4. Latin America
      1. Introduction
      2. Brazil
      3. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. South Africa
      4. Rest of Middle East & Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Abbott LaboratoriesOverview
      1. Product Analysis
      2. Strategic Evaluation and Operations
      3. Financial analysis
      4. Legal issues
      5. Recent Developments
      6. SWOT analysis
      7. Analyst View
    2. Johnson and Johnson
    3. Siemens Healthcare
    4. Becton Dickinson
    5. Roche Diagnostics
    6. Beckman Coulter Inc.
    7. Biomérieux
    8. Ortho Clinical Diagnostics, Inc.
    9. Bio-Rad Laboratories, Inc.
    10. Danaher Corporation
    11. Sysmex Corporation
    12. Thermo Fisher Scientific, Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global In-Vitro Diagnostics Market Market, By Region, From 2021 to 2026 (USD Million)
  2. Global In-Vitro Diagnostics Market Market, By Type, From 2021 to 2026 (USD Million)
  3. Global Instruments Market, By Region, From 2021 to 2026 (USD Million) 
  4. Global Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)   
  5. Global Software Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million)   
  7. Global Hematology Market, By Region, From 2021 to 2026 (USD Million) 
  8. Global Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million) 
  10. Global Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Microbiology Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Diabetes Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Cardiology Market, By Region, From 2021 to 2026 (USD Million) 
  17. Global Nephrology Market, By Region, From 2021 to 2026 (USD Million)
  18. Global Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Drug Testing Market, By Region, From 2021 to 2026 (USD Million)
  20. Global HIV Market, By Region, From 2021 to 2026 (USD Million)
  21. North America Global In-Vitro Diagnostics Market Market, By Region, From 2021 to 2026 (USD Million) 
  22. North America Global In-Vitro Diagnostics Market Market, By Type, From 2021 to 2026 (USD Million)
  23. North America Instruments Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)  
  25. North America Software Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million)  
  27. North America Hematology Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million)
  30. North America Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Microbiology Market, By Region, From 2021 to 2026 (USD Million) 
  32. North America Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Diabetes Market, By Region, From 2021 to 2026 (USD Million)
  34. North America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)   
  36. North America Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  37. North America Nephrology Market, By Region, From 2021 to 2026 (USD Million) 
  38. North America Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Million)
  39. North America Drug Testing Market, By Region, From 2021 to 2026 (USD Million)
  40. North America HIV Market, By Region, From 2021 to 2026 (USD Million)
  41. United States Market, By Product, From 2021 to 2026 (USD Million)
  42. United States Market, By Technology, From 2021 to 2026 (USD Million)
  43. United States Market, By Application, From 2021 to 2026 (USD Million)
  44. Canada Market, By Product, From 2021 to 2026 (USD Million)   
  45. Canada Market, By Technology, From 2021 to 2026 (USD Million)
  46. Canada Market, By Application, From 2021 to 2026 (USD Million)
  47. Europe Global In-Vitro Diagnostics Market Market, By Region, From 2021 to 2026 (USD Million)
  48. Europe Global In-Vitro Diagnostics Market Market, By Type, From 2021 to 2026 (USD Million)
  49. Europe Instruments Market, By Region, From 2021 to 2026 (USD Million)
  50. Europe Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million) 
  51. Europe Software Market, By Region, From 2021 to 2026 (USD Million)   
  52. Europe Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million) 
  53. Europe Hematology Market, By Region, From 2021 to 2026 (USD Million)
  54. Europe Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  55. Europe Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million)
  56. Europe Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Microbiology Market, By Region, From 2021 to 2026 (USD Million)
  58. Europe Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million) 
  59. Europe Diabetes Market, By Region, From 2021 to 2026 (USD Million)   
  60. Europe Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)
  61. Europe Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)  
  62. Europe Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  63. Europe Nephrology Market, By Region, From 2021 to 2026 (USD Million)
  64. Europe Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Million)
  65. Europe Drug Testing Market, By Region, From 2021 to 2026 (USD Million) 
  66. Europe HIV Market, By Region, From 2021 to 2026 (USD Million) 
  67. U.K. Market, By Product, From 2021 to 2026 (USD Million)
  68. U.K. Market, By Technology, From 2021 to 2026 (USD Million)   
  69. U.K. Market, By Application, From 2021 to 2026 (USD Million)   
  70. Germany Market, By Product, From 2021 to 2026 (USD Million)
  71. Germany Market, By Technology, From 2021 to 2026 (USD Million)
  72. Germany Market, By Application, From 2021 to 2026 (USD Million)
  73. France Market, By Product, From 2021 to 2026 (USD Million)
  74. France Market, By Technology, From 2021 to 2026 (USD Million)
  75. France Market, By Application, From 2021 to 2026 (USD Million) 
  76. Italy Market, By Product, From 2021 to 2026 (USD Million)
  77. Italy Market, By Technology, From 2021 to 2026 (USD Million)  
  78. Italy Market, By Application, From 2021 to 2026 (USD Million)  
  79. Spain Market, By Product, From 2021 to 2026 (USD Million)
  80. Spain Market, By Technology, From 2021 to 2026 (USD Million)
  81. Spain Market, By Application, From 2021 to 2026 (USD Million)
  82. Asia-Pacific Global In-Vitro Diagnostics Market Market, By Region, From 2021 to 2026 (USD Million)
  83. Asia-Pacific Global In-Vitro Diagnostics Market Market, By Type, From 2021 to 2026 (USD Million)
  84. Asia-Pacific Instruments Market, By Region, From 2021 to 2026 (USD Million)
  85. Asia-Pacific Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)
  86. Asia-Pacific Software Market, By Region, From 2021 to 2026 (USD Million)
  87. Asia-Pacific Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million)
  88. Asia-Pacific Hematology Market, By Region, From 2021 to 2026 (USD Million)
  89. Asia-Pacific Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  90. Asia-Pacific Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million)
  91. Asia-Pacific Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million) 
  92. Asia-Pacific Microbiology Market, By Region, From 2021 to 2026 (USD Million)  
  93. Asia-Pacific Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million) 
  94. Asia-Pacific Diabetes Market, By Region, From 2021 to 2026 (USD Million) 
  95. Asia-Pacific Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)
  96. Asia-Pacific Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)
  97. Asia-Pacific Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  98. Asia-Pacific Nephrology Market, By Region, From 2021 to 2026 (USD Million)
  99. Asia-Pacific Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Million)
  100. Asia-Pacific Drug Testing Market, By Region, From 2021 to 2026 (USD Million)   
  101. Asia-Pacific HIV Market, By Region, From 2021 to 2026 (USD Million)
  102. China Market, By Product, From 2021 to 2026 (USD Million)
  103. China Market, By Technology, From 2021 to 2026 (USD Million)
  104. China Market, By Application, From 2021 to 2026 (USD Million)
  105. India Market, By Product, From 2021 to 2026 (USD Million)
  106. India Market, By Technology, From 2021 to 2026 (USD Million) 
  107. India Market, By Application, From 2021 to 2026 (USD Million) 
  108. Japan Market, By Product, From 2021 to 2026 (USD Million)
  109. Japan Market, By Technology, From 2021 to 2026 (USD Million)
  110. Japan Market, By Application, From 2021 to 2026 (USD Million)
  111. Rest Of Asia-Pacific Market, By Product, From 2021 to 2026 (USD Million) 
  112. Rest Of Asia-Pacific  Market, By Technology, From 2021 to 2026 (USD Million)
  113. Rest Of Asia-Pacific  Market, By Application, From 2021 to 2026 (USD Million)
  114. Latin America Global In-Vitro Diagnostics Market Market, By Region, From 2021 to 2026 (USD Million)   
  115. Latin America Global In-Vitro Diagnostics Market Market, By Type, From 2021 to 2026 (USD Million)
  116. Latin America Instruments Market, By Region, From 2021 to 2026 (USD Million)
  117. Latin America Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)
  118. Latin America Software Market, By Region, From 2021 to 2026 (USD Million) 
  119. Latin America Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million)
  120. Latin America Hematology Market, By Region, From 2021 to 2026 (USD Million)
  121. Latin America Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  122. Latin America Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million)
  123. Latin America Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  124. Latin America Microbiology Market, By Region, From 2021 to 2026 (USD Million)
  125. Latin America Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million)
  126. Latin America Diabetes Market, By Region, From 2021 to 2026 (USD Million) 
  127. Latin America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)  
  128. Latin America Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)
  129. Latin America Cardiology Market, By Region, From 2021 to 2026 (USD Million)  
  130. Latin America Nephrology Market, By Region, From 2021 to 2026 (USD Million)
  131. Latin America Autoimmune Diseases Market, By Region, From 2021 to 2026 (USD Million) 
  132. Latin America Drug Testing Market, By Region, From 2021 to 2026 (USD Million) 
  133. Latin America HIV Market, By Region, From 2021 to 2026 (USD Million)
  134. Brazil Market, By Product, From 2021 to 2026 (USD Million)
  135. Brazil Market, By Technology, From 2021 to 2026 (USD Million)
  136. Brazil Market, By Application, From 2021 to 2026 (USD Million)
  137. Mexico Market, By Product, From 2021 to 2026 (USD Million)   
  138. Mexico Market, By Technology, From 2021 to 2026 (USD Million)
  139. Mexico Market, By Application, From 2021 to 2026 (USD Million)
  140. Rest of Latin America Market, By Product, From 2021 to 2026 (USD Million)
  141. Rest of Latin America Market, By Technology, From 2021 to 2026 (USD Million) 
  142. Rest of Latin America Market, By Application, From 2021 to 2026 (USD Million) 
  143. Middle East & Africa Global In-Vitro Diagnostics Market Market, By Region, From 2021 to 2026 (USD Million) 
  144. Middle East & Africa Global In-Vitro Diagnostics Market Market, By Type, From 2021 to 2026 (USD Million)
  145. Middle East & Africa Instruments Market, By Region, From 2021 to 2026 (USD Million)  
  146. Middle East & Africa Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)
  147. Middle East & Africa Software Market, By Region, From 2021 to 2026 (USD Million)
  148. Middle East & Africa Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Million)
  149. Middle East & Africa Hematology Market, By Region, From 2021 to 2026 (USD Million)  
  150. Middle East & Africa Immunoassays Market, By Region, From 2021 to 2026 (USD Million)
  151. Middle East & Africa Coagulation and Hemostasis Market, By Region, From 2021 to 2026 (USD Million)  
  152. Middle East & Africa Molecular Diagnostics Market, By Region, From 2021 to 2026 (USD Million) 
  153. Middle East & Africa Microbiology Market, By Region, From 2021 to 2026 (USD Million)
  154. Middle East & Africa Other IVD technologies Market, By Region, From 2021 to 2026 (USD Million)
  155. Middle East & Africa Diabetes Market, By Region, From 2021 to 2026 (USD Million)
  156. Middle East & Africa Infectious Diseases Market, By Region, From 2021 to 2026 (USD Million)
  157. Middle East & Africa Oncology/Cancer Market, By Region, From 2021 to 2026 (USD Million)
  158. Middle East & Africa Cardiology Market, By Region, From 2021 to 2026 (USD Million)
  159. Middle East & Africa Nephrology Market, By Region, From 2020 to 2025 (USD Billion)  

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4254

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample